DDM Professor Mauricio Reyes and his research group at the ARTORG Center for Biomedical Engineering Research, University of Bern, will contribute to the newly funded project TTRAIL (Trustworthy Transferable Radiotherapy with Artificial Intelligence), which has been selected under the latest Marie Skłodowska-Curie Actions (MSCA) Doctoral Networks call. The programme is part of a €617 million investment by the European Union to support cutting-edge doctoral training across Europe.
TTRAIL aims to train 15 doctoral researchers, referred to as “AIRTISTs”, to become the next generation of translational AI scientists in radiotherapy. The project focuses on developing trustworthy and transferable AI systems that can be integrated into clinical practice.
Within this initiative, Prof. Reyes’s group will lead the development of next-generation explainable AI systems for radiation therapy. Their work will also establish clinically relevant training paradigms for AI-driven autocontouring, an essential process in radiotherapy planning that defines tumour and organ boundaries.
The project is led by Principal Investigator Oscar Acosta and coordinated by Université de Rennes and the Laboratoire Traitement du Signal et de l’Image (LTSI). It brings together an extensive international consortium of academic institutions, industry leaders, and clinical partners.
Academic collaborators include institutions such as The University of Manchester, Karlsruhe Institute of Technology, and Politecnico di Milano, among others. Industry partners include Siemens Healthineers, Brainlab, and Dassault Systèmes, ensuring strong links between research, technology development, and clinical application.
Clinical partners across Europe will further support the programme by providing real-world healthcare environments for testing and validation.
“Being part of TTRAIL allows our lab to push the boundaries of explainable AI in radiotherapy. Training the next generation of AI scientists in a clinical context is an exciting opportunity to make cancer treatments safer and more precise.”, says DDM Prof. Mauricio Reyes.
The selection of TTRAIL highlights the growing importance of interdisciplinary collaboration in tackling complex healthcare challenges. For the Department of Digital Medicine, participation in this prestigious MSCA Doctoral Network reinforces its position at the forefront of AI-driven medical innovation.
With the project now officially funded, the consortium is preparing to begin its work on shaping the future of AI in radiotherapy, aiming to make treatments more precise, transparent, and clinically effective.
Learn more about the MSCA Doctoral Network call here.